Overview
- 16 inspections across 16 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2017-09-14.
At a glance
Inspections
16
Sites
16
Observations
1
Career since
May 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Rhode Island Blood Center, A Division of New York Blood Center, Inc. | 14 Sep 2017 | Biologics | |
| CSL Plasma | 13 Jul 2017 | Biologics | |
| Biotest Pharmaceuticals Corporation | 10 May 2017 | Biologics | |
| CSL Plasma Inc. | 8 Dec 2016 | Biologics | |
| CSL Plasma Inc. | 19 Oct 2016 | Biologics |
Sites inspected
Rhode Island Blood Center, A Division of New York Blood Center, Inc.Providence, United States1 insp.
CSL PlasmaFort Gratiot, United States1 insp.
Biotest Pharmaceuticals CorporationBrookings, United States1 insp.
CSL Plasma Inc.Flint, United States1 insp.
CSL Plasma Inc.Orange City, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Rosia E Nesbitt2 shared
Miriam Montes1 shared
Kanaeko R Ravenell1 shared
Patricia E Weddington1 shared
Camilla S Smith1 shared
Susan M Miller1 shared
Gloria A Milster1 shared
Roger D Gawne1 shared
Barbara A Rusin1 shared
Diane Hall1 shared
Full investigator report
Get the verbatim findings behind Mary E Baker-Brown's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site